• helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Glycomics Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global glycomics market looks promising with opportunities in drug discovery & development and disease diagnostics. The global glycomics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing research and development activities related to drug discovery, rising investment by governments and organizations for academic research for development of new glycomics and glycobiology tools, and growing proteomics market.

A total of XX figures / charts and XX tables are provided in more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global glycomics market report, please download the report brochure.
 
 

 
In this market, drug discovery and development is the largest application of glycomics, whereas academic research and institutes is the largest end user. Growth in various segments of the glycomics market are given below:
 
 


 
The study includes trends and forecast for the global glycomics market by product, application, end user, and region as follows:
 
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Enzymes
    • Glycosidases & Neuramidases
    • Glycosyltransferases & Sialyltransferases
    • Other Enzymes
  • Instruments
    • Mass Spectrometry Instruments
    • Chromatography Instruments
    • Arrays
    • Other Instruments
  • Carbohydrates
    • Oligosaccharides
    • Monosaccharides
    • Other Carbohydrates
  • Reagents & Chemicals

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Drug Discovery & Development
  • Disease Diagnostics
  • Cancer Diagnostics
  • Other Disease Diagnostics
  • Other Applications

By End User [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
    • United States
    • Canada 
    • Mexico
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil
 

Some of the glycomics companies profiled in this report include Merck, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Takara Bio, S-BIO, Waters Corporation, Asparia Glycomics, and Bio-Techne.

Lucintel forecasts that the drug discovery and development will remain the largest segment over the forecast period due to increasing research and development activities related to glycomics and proteomics.

Within this market, academic and research institutes will remain the largest segment over the forecast period due to increasing research and development activities and growing adoption of glycan structure data analysis by research centers.

North America will remain the largest region over the forecast period due to government fundings for research and development activities and presence of advanced healthcare infrastructure in the region. 



 
Features of the Global Glycomics Market
 
  • Market Size Estimates: Global glycomics market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global glycomics market size by various segments, such as product, application, and end user in terms of value.
  • Regional Analysis: Global glycomics market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, application, end user, and region for the global glycomics market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global glycomics market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.



 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global glycomics market by product (enzymes (glycosidases & neuramidases, glycosyltransferases & sialyltransferases, and other enzymes), instruments (mass spectrometry instruments, chromatography instruments, arrays, and other instruments), carbohydrates (oligosaccharides, monosaccharides, and other carbohydrates), and reagents & chemicals), application (drug discovery & development, disease diagnostics (cancer diagnostics and other disease diagnostics), and other applications), end user (academic research institutes, pharmaceutical & biotechnology companies, and clinical laboratories), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global glycomics market?
Q.5 What are the business risks and threats to the global glycomics market?
Q.6 What are emerging trends in this glycomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this glycomics market?
Q.8 What are the new developments in this glycomics market? Which companies are leading these developments?
Q.9 Who are the major players in this glycomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this glycomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global glycomics market?

 


Report Scope


Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)
2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals), Application (Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications), and End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Customization 10% Customization without Any Additional Cost

Table of Contents


1. Executive Summary

2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Glycomics Market Trends and Forecast
3.3: Global Glycomics Market by Product
3.3.1: Enzymes 
3.3.1.1: Glycosidases & Neuramidases
3.3.1.2: Glycosyltransferases & Sialyltransferases
3.3.1.3: Other Enzymes
3.3.2: Instruments 
3.3.2.1: Mass Spectrometry Instruments
3.3.2.2: Chromatography Instruments
3.3.2.3: Arrays
3.3.2.4: Other Instruments)
3.3.3: Carbohydrates
3.3.3.1: Oligosaccharides
3.3.3.2: Monosaccharides
3.3.3.3: Other Carbohydrates
3.3.4: Reagents & Chemicals
3.4: Global Glycomics Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Disease Diagnostics 
3.4.2.1: Cancer Diagnostics
3.4.2.2: Other Disease Diagnostics
3.4.3: Other Applications 
3.5: Global Glycomics Market by End User
3.5.1: Academic Research Institutes
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Clinical Laboratories

4. Market Trends and Forecast Analysis by Region
4.1: Global Glycomics Market by Region
4.2: North American Glycomics Market
4.2.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.2.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications
4.2.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories 
4.2.4: The United States Glycomics Market
4.2.5: The Canadian Glycomics Market
4.2.6: The Mexican Glycomics Market
4.3: European Glycomics Market
4.3.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.3.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications 
4.3.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories 
4.3.4: The Glycomics Market of United Kingdom
4.3.5: The Spanish Glycomics Market
4.3.6: The German Glycomics Market
4.3.7: The French Glycomics Market
4.4: APAC Glycomics Market
4.4.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.4.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications 
4.4.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories 
4.4.4: The Chinese Glycomics Market
4.4.5: The Indian Glycomics Market
4.4.6: The Vietnamese Glycomics Market
4.5: ROW Glycomics Market
4.5.1: Market by Product: Enzymes (Glycosidases & Neuramidases, Glycosyltransferases & Sialyltransferases, and Other Enzymes), Instruments (Mass Spectrometry Instruments, Chromatography Instruments, Arrays, and Other Instruments), Carbohydrates (Oligosaccharides, Monosaccharides, and Other Carbohydrates), and Reagents & Chemicals
4.5.2: Market by Application: Drug Discovery & Development, Disease Diagnostics (Cancer Diagnostics and Other Disease Diagnostics), and Other Applications 
4.5.3: Market by End User: Academic Research Institutes, Pharmaceutical & Biotechnology Companies, and Clinical Laboratories 
4.5.4: Brazilian Glycomics Market

5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Glycomics Market by Product
7.1.2: Growth Opportunities for the Global Glycomics Market by Application
7.1.3: Growth Opportunities for the Global Glycomics Market by End User
7.1.4: Growth Opportunities for the Global Glycomics Market by Region
7.2: Emerging Trends in the Global Glycomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Glycomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glycomics Market
7.3.4: Certification and Licensing

8. Company Profiles of Leading Players
8.1: Merck KGaA 
8.2: Agilent Technologies, Inc. 
8.3: Thermo Fisher Scientific, Inc.
8.4: New England Biolabs, Inc.
8.5: Shimadzu Corporation
8.6: Takara Bio, Inc. 
8.7: S-BIO
8.8: Waters Corporation
8.9: Asparia Glycomics S.L. 
8.10: Bio-Techne Corporation
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Glycomics Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150-page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Below is a brief summary of the primary interviews that were conducted by job function for this report.